Drug use among medical students in São Paulo, Brazil: a cross-sectional study during the coronavirus disease 2019 pandemic

Imagem de Miniatura
Arquivos
art_LEMOS-SANTOS_Drug_use_among_medical_students_in_Sao_Paulo_2024.PDF (218.93 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOCIACAO PAULISTA MEDICINA
Autores
Citação
SAO PAULO MEDICAL JOURNAL, v.142, n.2, article ID e2022493, 10p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: Medical students demonstrate higher rates of substance use than other university students and the general population. The challenges imposed by the coronavirus disease 2019 (COVID-19) pandemic raised significant concerns about mental health and substance use.OBJECTIVES: Assess the current prevalence of substance use among medical students at the University of Sao Paulo and evaluate the impact of the COVID-19 pandemic on drug consumption.DESIGN AND SETTING: A cross-sectional study was conducted on 275 medical students from the UniverMETHODS: Substance use (lifetime, previous 12 months, and frequency of use before and during the COVID-19 pandemic) and socioeconomic data were assessed using an online self-administered questionnaire. Symptoms of depression were assessed using the Patient Health Questionnaire-9. RESULTS: Alcohol was the most consumed substance in their lifetime (95.6%), followed by illicit drugs (61.1%), marijuana (60%), and tobacco (57.5%). The most commonly consumed substances in the previous year were alcohol (82.9%), illicit drugs (44.7%), marijuana (42.5%), and tobacco (36%). Students in the first two academic years consumed fewer substances than those from higher years. There was a decreasing trend in the prevalence of most substances used after the COVID-19 pandemic among sporadic users. However, frequent users maintained their drug use patterns.CONCLUSION: The prevalence of substance use was high in this population and increased from the basic to the clinical cycle. The COVID-19 pandemic may have affected the frequency of drug use and prevalence estimates.
Palavras-chave
Students, medical, Prevalence, COVID-19, Mental health, Education
URI
https://observatorio.fm.usp.br/handle/OPI/57723
Referências
  1. [Anonymous], 2014, Medical Student Research Journal
  2. Ayala EE, 2017, MED EDUC ONLINE, V22, DOI 10.1080/10872981.2017.1392824
  3. Babalola EO, 2014, ANN MED HEALTH SCI R, V4, P397, DOI 10.4103/2141-9248.133467
  4. Bahji A, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.33994
  5. Bastos FI, 2017, III Levantamento Nacional sobre o uso de drogas pela populacao brasileira
  6. Bazin B, 2021, SUBST USE MISUSE, V56, P67, DOI 10.1080/10826084.2020.1837167
  7. Berg CJ, 2018, PEDIATRICS, V141, pS10, DOI [10.1542/peds.2017-1026E, 10.1542/peds.2017-1026e]
  8. Bierhoff J, 2019, SUBST USE MISUSE, V54, P1365, DOI 10.1080/10826084.2019.1581220
  9. Bonaccorso S, 2019, NEUROTOXICOLOGY, V74, P282, DOI 10.1016/j.neuro.2019.08.002
  10. Boniatti MM, 2007, DRUG ALCOHOL REV, V26, P279, DOI 10.1080/09595230701247715
  11. Miramontes AB, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162939
  12. Candido FJ, 2018, REV ASSOC MED BRAS, V64, P462
  13. Chu JJ, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0062-0
  14. Czeisler MÉ, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]
  15. Da Silveira DX, 2008, ADDICT BEHAV, V33, P490, DOI 10.1016/j.addbeh.2007.10.005
  16. Moutinho ILD, 2019, J ADDICT MED, V13, P295, DOI 10.1097/ADM.0000000000000497
  17. de Andrade Arthur Guerra, Presidencia da Republica. Secretaria Nacional de Politicas sobre Drogas. I Levantamento Nacional sobre o Uso de Alcool, Tabaco e Outras Drogas entre Universitarios das 27 Capitais Brasileiras/Secretaria Nacional de Politicas sobre Drogas
  18. GREA/IPQ-HC/FMUSP
  19. de Oliveira LG, 2009, REV BRAS PSIQUIATR, V31, P227, DOI 10.1590/S1516-44462009000300008
  20. Dumas TM, 2020, J ADOLESCENT HEALTH, V67, P354, DOI 10.1016/j.jadohealth.2020.06.018
  21. Emanuel RM, 2013, J GEN INTERN MED, V28, P1028, DOI 10.1007/s11606-012-2249-4
  22. Gignon M, 2015, WORKPLACE HEALTH SAF, V63, P54, DOI 10.1177/2165079915570917
  23. Grabski M, 2020, BEHAV BRAIN RES, V392, DOI 10.1016/j.bbr.2020.112629
  24. Haas GM, 2019, BRAZ J PSYCHIAT, V41, P363, DOI 10.1590/1516-4446-2018-0328
  25. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  26. Instituto Nacional do Cancer, 2022, Data and smoking numbers
  27. Jackson ER, 2016, ACAD MED, V91, P1251, DOI 10.1097/ACM.0000000000001138
  28. Johnston LD., 2021, Monitoring the future national survey results on drug use, 1975-2017: Overview, key findings on adolescent drug use
  29. Kang M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249317
  30. Kim JH, 2021, DRUG ALCOHOL DEPEN, V218, DOI 10.1016/j.drugalcdep.2020.108364
  31. Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
  32. Passos SRL, 2006, SOC PSYCH PSYCH EPID, V41, P989, DOI 10.1007/s00127-006-0114-7
  33. Lev-Ran S, 2013, AM J ADDICTION, V22, P7, DOI 10.1111/j.1521-0391.2013.00321.x
  34. Malbergier A, 2012, REV BRAS PSIQUIATR, V34, P16, DOI 10.1590/S1516-44462012000100005
  35. Mannes PZ, 2021, JAMA PSYCHIAT, V78, P1393, DOI 10.1001/jamapsychiatry.2021.2666
  36. Mounteney J, 2018, INT J DRUG POLICY, V51, P36, DOI 10.1016/j.drugpo.2017.09.016
  37. Oreskovich MR, 2015, AM J ADDICTION, V24, P30, DOI 10.1111/ajad.12173
  38. Orsini CA, 2014, APPETITE, V78, P76, DOI 10.1016/j.appet.2014.03.013
  39. Palamar JJ, 2017, DRUG ALCOHOL DEPEN, V181, P20, DOI 10.1016/j.drugalcdep.2017.09.011
  40. Prati G, 2021, PSYCHOL MED, V51, P201, DOI 10.1017/S0033291721000015
  41. Reiff CM, 2020, AM J PSYCHIAT, V177, P391, DOI 10.1176/appi.ajp.2019.19010035
  42. Reinstadler V, 2021, SCI TOTAL ENVIRON, V757, DOI 10.1016/j.scitotenv.2020.144006
  43. Roncero C, 2014, J ADDICT DIS, V33, P277, DOI 10.1080/10550887.2014.969600
  44. Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324
  45. Sanchez-Villegas Almudena, 2021, Adicciones, V0, P1725, DOI 10.20882/adicciones.1725
  46. Seabold S., 2010, 9 PYTHON SCI C, DOI 10.25080/MAJORA-92BF1922-011
  47. Sessa B, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00138
  48. Boclin KDS, 2020, SAO PAULO MED J, V138, P27, DOI [10.1590/1516-3180.2019.0182.R1.21102019, 10.1590/1516-3180.2019.0182.r1.21102019]
  49. Stempliuk VD, 2005, REV BRAS PSIQUIATR, V27, P185, DOI 10.1590/S1516-44462005000300006
  50. Talih F, 2018, ACAD PSYCHIATR, V42, P288, DOI 10.1007/s40596-017-0879-x
  51. Tjia J, 2005, J AM COLL HEALTH, V53, P219, DOI 10.3200/JACH.53.5.219-224
  52. Tockus Deborah, 2008, J. bras. psiquiatr., V57, P184, DOI 10.1590/S0047-20852008000300005
  53. United Nations Office on Drugs and Crime, 2020, World drug report 2020
  54. Van Rossum G., 1995, Python Reference Manual, DOI 10.5555/869369
  55. Vanderbruggen N, 2020, EUR ADDICT RES, V26, P309, DOI 10.1159/000510822
  56. Vayr F, 2019, DRUG ALCOHOL DEPEN, V199, P116, DOI 10.1016/j.drugalcdep.2019.04.004
  57. Wagner GA, 2007, REV BRAS PSIQUIATR, V29, P123, DOI 10.1590/S1516-44462006005000033
  58. White HR, 2020, J STUD ALCOHOL DRUGS, V81, P725, DOI 10.15288/jsad.2020.81.725
  59. Yockey RA, 2020, DRUG ALCOHOL DEPEN, V212, DOI 10.1016/j.drugalcdep.2020.108071

Coleções
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/IPer
Artigos e Materiais de Revistas Científicas - LIM/23
Artigos e Materiais de Revistas Científicas - LIM/27
Artigos e Materiais de Revistas Científicas - LIM/63
Carregar mais